Recent studies have associated the TRIB1 gene with the development of several tumors including colorectal (Wang et al., 2017), leukemia (Yoshida et al., 2013), and hepatocellular (Ye et al., 2017) cancers. This evidence concerns the gene TRIB1 and leukemia.